News | Radiation Therapy | July 05, 2019

Aktina Medical Partners With Elekta for Global Distribution of Interlocking SRS Cones

Cones allow radiation therapy clinics to deliver stereotactic radiosurgery with existing general purpose radiotherapy equipment

Aktina Medical Partners With Elekta for Global Distribution of Interlocking SRS Cones

July 5, 2019 — Aktina Medical announced that Elekta Instrument AB, based in Sweden, will offer and distribute the Aktina line of patented SRS Cones globally for use in cancer treatments and other appropriate radiation therapies.

The use of calibrated cones in stereotactic radiosurgery has grown in recent years, particularly in clinics that do not have access to the most advanced special-purpose radiation treatment equipment. By using the Aktina SRS Cones, such clinics can deliver highly accurate SRS treatments using their existing general-purpose radiation treatment equipment.

Unlike previous solutions, the Aktina SRS Cone system features lead-based interlocking cones with stainless steel sleeves that have carved channels and grooves that match corresponding channels and grooves carved into the applicator. As each cone is inserted into the applicator, they depress (or don’t depress) specific switches, and confirm by their own insertion that they are the proper size cone for the programmed dosage. The control software, which has been integrated with the cones and applicator, compares the installed cone with the programmed plan and confirms they match before proceeding. In this way, automated treatment verification lets technicians benefit from fast, simple equipment setup while ensuring they deliver the correct dosage and treatment specified for the patients.

For more information: www.aktina.com, www.elekta.com

Related Content

Newly released study results present a strong case for lung cancer screening in New Zealand — particularly for Māori whose mortality rates are between three and four times higher than other ethnic groups.

Image courtesy of Siemens Healthineers

News | Lung Imaging | September 30, 2020
September 30, 2020 — Newly released study results present a strong case for...
he Centers for Medicare and Medicaid Services (CMS) published the “Specialty Care Models to Improve Quality of Care and Reduce Expenditures (CMS-5527)” final rule.

Getty Images

News | Radiation Oncology | September 29, 2020
September 29, 2020 — On Sept.
Important milestone demonstrates the unrivalled experience, technological innovation and global market leadership of IBA and its clinical partners
News | Proton Therapy | September 25, 2020
September 25, 2020 — IBA (Ion Beam Applications SA) announced that more than 100,000 patients have now been treated w
Philips Azurion Lung Edition supports high precision diagnosis and minimally invasive therapy in one room
News | Lung Imaging | September 21, 2020
September 21, 2020 — Philips introduced...
Final rule includes mandatory participation for nearly 1,000 practices and does not allow sufficient time for transition

Getty Images

News | Radiation Oncology | September 21, 2020
September 21, 2020 — In response to the September 18 ...
According to a new report published by P&S Intelligence, the global radiotherapy market is expected to expand from $7.2M in 2019 to $17M by 2030.

Image courtesy of Accuray

Feature | Radiation Therapy | September 21, 2020 | By Melinda Taschetta-Millane
According to a...
Breast cancer patients whose disease has spread to their brains fare better if their metastases are picked up before they begin to cause symptoms, according to a study presented at the 12th European Breast Cancer Conference.

Getty Images

News | Breast Imaging | September 21, 2020
September 21, 2020 — Breast cancer patients whose disease has spread to their brains fare better if their metastases
Data from latest research presented at the ESMO Virtual Congress 2020 suggests COVID-19 pandemic halts cancer care and damages oncologists' wellbeing

Getty Images

News | Coronavirus (COVID-19) | September 17, 2020
September 17, 2020 — Delays and cancellation of cancer treatments and other safety measures undertaken to minimize th
Varian Drives Next Evolution of Proton Treatment Planning with Eclipse v16.1
News | Treatment Planning | September 15, 2020
September 15, 2020 — Varian announced it has received FDA 510(k) clearance for its Eclipse v16.1 treatment planning s